Literature DB >> 2686677

Immunotoxins--entry into cells and mechanisms of action.

S Olsnes, K Sandvig, O W Petersen, B van Deurs.   

Abstract

Immunotoxins, that is conjugates of enzymatically active toxins with antibodies against cell surface antigens, are being used in targeted cell destruction. The directed toxin enters the cytosol of the target cells and inactivates components of the protein synthesis machinery. In this review, Sjur Olsnes, Kirsten Sandvig, Ole W. Petersen and Bo van Deurs discuss the mechanism of action of such conjugates and how they enter the cytosol. Emphasis is placed on points that should be considered in the preparation of efficient conjugates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2686677

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  17 in total

Review 1.  What future for therapeutic prevention of type 1 (insulin-dependent) diabetes mellitus?

Authors:  P Pozzilli; A Signore; D Andreani
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

Review 2.  Immunotherapy through the IL-2 receptor.

Authors:  H A Verheul; M Verveld; E S Bos
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

3.  Uptake of injected 125I-ricin by rat liver in vivo. Subcellular distribution and characterization of the internalized ligand.

Authors:  J P Frénoy; E Turpin; M Janicot; F Gehin-Fouque; B Desbuquois
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

4.  Retrograde transport of mutant ricin to the endoplasmic reticulum with subsequent translocation to cytosol.

Authors:  A Rapak; P O Falnes; S Olsnes
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting.

Authors:  Simon Beaudoin; Michel Paquette; Laurent Fafard-Couture; Mylene A Tremblay; Roger Lecomte; Brigitte Guérin; Jeffrey V Leyton
Journal:  J Vis Exp       Date:  2018-03-08       Impact factor: 1.355

6.  Effects of cellular pharmacology on drug distribution in tissues.

Authors:  R K Rippley; C L Stokes
Journal:  Biophys J       Date:  1995-09       Impact factor: 4.033

7.  Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate.

Authors:  U Roelcke; K L Leenders; K von Ammon; E W Radü; P Vontobel; I Günther; M Psylla
Journal:  J Neurooncol       Date:  1996-08       Impact factor: 4.130

8.  A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.

Authors:  P Casalini; M Caldera; S Canevari; S Ménard; D Mezzanzanica; E Tosi; M Gadina; M I Colnaghi
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

9.  Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.

Authors:  K Sandvig; M Ryd; O Garred; E Schweda; P K Holm; B van Deurs
Journal:  J Cell Biol       Date:  1994-07       Impact factor: 10.539

10.  Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin.

Authors:  O Klingenberg; S Olsnes
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.